|
Jenburkt Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
472.25 Cr.
|
P/BV
|
2.40
|
Book Value (Rs.)
|
446.47
|
|
52 Week High/Low (Rs.)
|
1340/944
|
FV/ML
|
10/1
|
P/E(X)
|
13.60
|
|
Bookclosure
|
11/07/2025
|
EPS (Rs.)
|
78.71
|
Div Yield (%)
|
1.93
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 78.71 | 72.65 | 58.86 | 53.90 | 48.58 |
| Diluted EPS (Rs.) | 78.71 | 72.65 | 58.86 | 53.90 | 48.58 |
| Cash EPS (Rs.) | 85.75 | 78.83 | 64.16 | 60.88 | 52.72 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 446.47 | 389.23 | 328.42 | 277.32 | 255.77 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 446.47 | 389.23 | 328.42 | 277.32 | 255.77 |
| Dividend / Share (Rs.) | 20.70 | 18.00 | 15.30 | 14.40 | 12.00 |
| Revenue From Operations / Share (Rs.) | 382.35 | 343.71 | 321.68 | 309.86 | 270.14 |
| PBDIT / Share (Rs.) | 122.45 | 106.75 | 85.62 | 80.42 | 70.17 |
| PBIT / Share (Rs.) | 115.41 | 100.57 | 80.32 | 75.30 | 66.03 |
| PBT / Share (Rs.) | 105.41 | 99.55 | 79.70 | 74.47 | 65.09 |
| Net Profit / Share (Rs.) | 78.71 | 72.64 | 58.86 | 55.76 | 48.58 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 32.02 | 31.05 | 26.61 | 25.95 | 25.97 |
| PBIT Margin (%) | 30.18 | 29.26 | 24.96 | 24.30 | 24.44 |
| PBT Margin (%) | 27.56 | 28.96 | 24.77 | 24.03 | 24.09 |
| Net Profit Margin (%) | 20.58 | 21.13 | 18.29 | 17.99 | 17.98 |
| Return on Networth / Equity (%) | 17.62 | 18.66 | 17.92 | 20.10 | 18.99 |
| Return on Capital Employeed (%) | 25.10 | 25.02 | 23.83 | 26.36 | 24.90 |
| Return On Assets (%) | 15.36 | 16.34 | 15.73 | 17.35 | 15.59 |
| Total Debt / Equity (X) | 0.00 | 0.01 | 0.00 | 0.01 | 0.04 |
| Asset Turnover Ratio (%) | 0.79 | 0.83 | 0.92 | 0.96 | 0.94 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 4.11 | 3.00 | 6.70 | 5.14 | 3.57 |
| Quick Ratio (X) | 3.52 | 2.53 | 6.18 | 4.62 | 3.10 |
| Inventory Turnover Ratio (X) | 14.99 | 17.39 | 16.80 | 1.22 | 1.34 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 21.06 | 24.46 | 22.38 | 20.99 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 19.40 | 22.44 | 20.49 | 19.34 |
| Earning Retention Ratio (%) | 0.00 | 78.94 | 75.54 | 77.62 | 79.01 |
| Cash Earning Retention Ratio (%) | 0.00 | 80.60 | 77.56 | 79.51 | 80.66 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 116.97 | 104.05 | 139.59 | 96.71 | 74.13 |
| Interest Coverage Ratio (Post Tax) (%) | 84.74 | 71.81 | 96.96 | 68.05 | 52.33 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 368.55 | 423.83 | 225.08 | 242.56 | 216.85 |
| EV / Net Operating Revenue (X) | 2.18 | 2.79 | 1.59 | 1.77 | 1.75 |
| EV / EBITDA (X) | 6.82 | 9.00 | 5.96 | 6.83 | 6.73 |
| MarketCap / Net Operating Revenue (X) | 2.50 | 2.94 | 2.14 | 2.15 | 2.10 |
| Retention Ratios (%) | 0.00 | 78.93 | 75.53 | 77.61 | 79.00 |
| Price / BV (X) | 2.14 | 2.60 | 2.10 | 2.40 | 2.22 |
| Price / Net Operating Revenue (X) | 2.50 | 2.94 | 2.14 | 2.15 | 2.10 |
| EarningsYield | 0.08 | 0.07 | 0.08 | 0.08 | 0.08 |
